PACB
Pacific Biosciences of California
1.60$
+12.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -670.1% | – | – | – | – | |
| – | -12.9% | +5.4% | +117.9% | -14.5% | +37.9% | -6.5% | +24.5% | +49.5% | +88.8% | +63.2% | +624.5% | |
| – | +39.2% | +41.3% | +4.0% | +13.8% | -29.2% | +6.9% | +360.4% | -2.6% | -8.3% | -1.5% | -41.3% | |
| – | +30.2% | +42.7% | +8.4% | +9.2% | -106.2% | – | – | +135.8% | – | – | – | |
| – | – | – | – | – | -153.0% | – | – | -356.9% | – | – | – | |
| – | +87.0% | +172.7% | +27.1% | -82.2% | +53.0% | -63.4% | +470.8% | +185.4% | -47.8% | -30.0% | -56.1% | |
| – | -56.0% | -272.7% | -89.6% | +2,380.0% | – | -453.5% | +209.4% | – | -96.0% | +2,593.4% | -6.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -13.2% | +80.8% | +11.2% | +46.2% | -92.0% | +2,635.6% | +39.7% | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +255.6% | +0.0% | +0.0% | – | -100.2% | +14.6% | -73.4% | -100.0% | |
| – | -13.2% | +80.8% | +4.4% | +55.8% | -75.2% | +848.6% | +364.4% | -99.2% | +1,108.3% | -137.0% | – | |
| – | -128.0% | – | – | – | +340.0% | +405.9% | +630.2% | -136.2% | – | – | – | |
| – | – | – | – | – | – | – | -734.3% | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.